Verona Pharma Plc ADR’s recent filing unveils that its President and CEO ZACCARDELLI DAVID unloaded Company’s shares for reported $3.21 million on Dec 05 ’24. In the deal valued at $5.01 per share,640,264 shares were sold. As a result of this transaction, ZACCARDELLI DAVID now holds 14,367,552 shares worth roughly $670.82 million.
Then, ZACCARDELLI DAVID sold 162,800 shares, generating $815,400 in total proceeds. Upon selling the shares at $5.01, the President and CEO now owns 14,204,752 shares.
Before that, ZACCARDELLI DAVID sold 67,608 shares. Verona Pharma Plc ADR shares valued at $338,162 were divested by the President and CEO at a price of $5.00 per share. As a result of the transaction, ZACCARDELLI DAVID now holds 15,007,816 shares, worth roughly $700.71 million.
ROTH MKM initiated its Verona Pharma Plc ADR [VRNA] rating to a Buy in a research note published on January 10, 2025; the price target was $68. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in early October with a ‘”an Overweight”‘ rating.
Price Performance Review of VRNA
On Monday, Verona Pharma Plc ADR [NASDAQ:VRNA] saw its stock jump 3.30% to $46.69. Over the last five days, the stock has gained 0.21%. Verona Pharma Plc ADR shares have risen nearly 0.54% since the year began. Nevertheless, the stocks have risen 135.21% over the past one year. While a 52-week high of $51.80 was reached on 01/07/25, a 52-week low of $11.39 was recorded on 01/10/25. SMA at 50 days reached $40.77, while 200 days put it at $26.29.
Levels Of Support And Resistance For VRNA Stock
The 24-hour chart illustrates a support level at 44.98, which if violated will result in even more drops to 43.28. On the upside, there is a resistance level at 48.09. A further resistance level may holdings at 49.50. The Relative Strength Index (RSI) on the 14-day chart is 57.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 43.68%. Stochastics %K at 51.46% indicates the stock is a holding.
How much short interest is there in Verona Pharma Plc ADR?
A steep rise in short interest was recorded in Verona Pharma Plc ADR stocks on 2024-12-31, growing by 0.54 million shares to a total of 6.9 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 6.36 million shares. There was a rise of 7.84%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 26, 2022 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $31 price target.
